A device that analyzes blood in premature infants with minimal blood loss
Automated microfluidic device for blood analysis in neonates
This study is testing a new device that can quickly analyze tiny blood samples from premature babies, helping doctors check for infections and jaundice while using less blood, which is safer for these little ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sersense, INC. NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11043396 on NIH RePORTER |
What this research studies
This research focuses on developing an automated microfluidic device designed to analyze blood samples from premature infants, who are at high risk for conditions like infections and jaundice. The device requires only a tiny amount of blood (about 5 microliters) and provides rapid results, significantly reducing the volume of blood drawn compared to traditional methods. By minimizing blood loss, this technology aims to decrease the risk of anemia and the need for blood transfusions in vulnerable neonates. The device is intended for use in neonatal intensive care units (NICUs), making it accessible for immediate clinical application.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature infants who require frequent blood tests for monitoring health conditions.
Not a fit: Patients who are not premature or do not require regular blood testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could greatly reduce the risk of anemia and transfusion-related complications in premature infants.
How similar studies have performed: Other research has shown promise in using microfluidic devices for blood analysis, indicating a potential for success with this novel approach.
Where this research is happening
Rochester, United States
- Sersense, INC. — Rochester, United States (Active)
Researchers
- Principal investigator: Gonzalez-Suarez, Alan M — Sersense, INC.
- Study coordinator: Gonzalez-Suarez, Alan M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.